🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 16 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/02/2005 45,90 45,90 41,00 41,80 -5,64% 10,68% 11.050
18/02/2005 42,30 45,50 42,30 44,30 +4,24% 7,57% 9.380
17/02/2005 42,70 43,00 41,30 42,50 +1,92% 3,98% 3.840
16/02/2005 44,00 44,10 40,50 41,70 -6,08% 8,18% 13.100
15/02/2005 46,40 46,40 43,80 44,40 -1,77% 5,60% 8.630
14/02/2005 47,10 47,10 43,82 45,20 +1,80% 6,96% 17.320
11/02/2005 42,40 46,30 41,00 44,40 +7,25% 12,50% 29.900
10/02/2005 42,30 42,80 41,00 41,40 -0,96% 4,26% 5.260
09/02/2005 41,80 42,60 41,50 41,80 +1,21% 2,63% 8.180
08/02/2005 40,90 41,80 40,16 41,30 +3,25% 4,01% 10.820
07/02/2005 39,80 40,90 39,10 40,00 +3,09% 4,52% 19.550
04/02/2005 38,50 39,50 38,50 38,80 +0,52% 2,60% 8.550
03/02/2005 40,00 40,00 38,50 38,60 -0,77% 3,75% 6.640
02/02/2005 39,60 39,80 38,00 38,90 +1,04% 4,55% 10.740
01/02/2005 39,90 39,90 37,50 38,50 +1,32% 6,02% 9.970
31/01/2005 39,90 39,90 38,00 38,00 +0,80% 4,76% 10.070
28/01/2005 42,30 42,30 37,70 37,70 -3,33% 10,87% 25.580
27/01/2005 39,90 39,90 38,30 39,00 -1,52% 4,01% 2.390
26/01/2005 35,40 39,60 35,40 39,60 +11,86% 11,86% 8.210
25/01/2005 35,00 38,10 34,00 35,40 -1,67% 11,71% 4.750
24/01/2005 39,60 39,90 35,60 36,00 -6,98% 10,86% 10.030
21/01/2005 40,50 40,50 38,62 38,70 -3,25% 4,64% 5.610
20/01/2005 39,70 40,50 39,10 40,00 +0,00% 3,53% 4.740
19/01/2005 40,00 42,20 39,20 40,00 +0,76% 7,50% 3.930
18/01/2005 41,30 42,60 38,90 39,70 -0,75% 8,96% 6.140
14/01/2005 41,20 41,20 38,60 40,00 +0,00% 6,31% 3.680
13/01/2005 42,00 42,00 40,00 40,00 -0,50% 4,76% 4.400
12/01/2005 39,50 42,20 38,70 40,20 +3,34% 8,86% 4.210
11/01/2005 40,00 41,10 38,50 38,90 -3,23% 6,50% 4.130
10/01/2005 43,90 44,40 39,50 40,20 -5,41% 11,16% 7.290